Hyper-phosphorylation of tau and NFTs correlated more directly with the progression of cognitive impairment and disease severity than Aβ burden, making it a critical therapeutic target (Huber et al., 2018; Arriagada et al., 1992). Here, MAPT is linked to Cognitive impairment.